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Abstract: 
 
The upper motor neuron dysfunction in amyotrophic lateral sclerosis 
was quantified using triple stimulation and more focal transcranial 
magnetic stimulation techniques that were developed to reduce recording 
variability. These measurements were combined with clinical and 
neurophysiological data to develop a novel random forest based 
supervised machine learning prediction model. This model was capable of 
predicting cross-sectional ALS disease severity as measured by the 
ALSFRSr scale with 97% overall accuracy and 99% precision. The machine 
learning model developed in this research provides a new, unique and 
objective diagnostic method for quantifying disease severity and 
identifying subtle changes in disease progression in ALS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amyotrophic lateral sclerosis (ALS) is a progressively fatal neuro-
degenerative condition. It is associated with a differential involvement of upper 
motor neuron (UMN) and lower motor neuron (LMN) pathways. To better 
understand the differential impact of UMN and LMN components on disease 
related disability and mortality, an objective quantification of different components 
in the ALS disease process is needed.  The UMN involvement in ALS is difficult 
to measure objectively. Its contribution to overall disease severity is important, 
yet not well quantified. The most widely used clinical measures for UMN 
involvement are: identification of overactive reflexes, detection and grading 
spasticity, eliciting a plantar response and timed repetitive functional tests. Such 
findings are not specific and difficult to precisely quantitate.  
 
Important components of the UMN system are the motor cortex and the 
corticospinal tract. The corticospinal tract is the pathway responsible for 
conveying kinematic (1, 2) and dynamic (3) state information from motor 
networks responsible for the control of voluntary muscle activity. Any functional 
loss in the corticomotoneuronal pathway can manifest as a loss of motor function 
(1) and impact disease severity in ALS. Hence, it is important to understand the 
disease severity changes in relation to corticospinal tract functional loss. 
 
Transcranial magnetic stimulation (TMS) allows non-invasive brain 
stimulation of the motor cortex and is helpful to quantitate UMN involvement (4). 
Though TMS measurements are useful for measuring UMN involvement, there is 
an inherent variability associated with the most commonly used TMS parameters. 
Therefore, the results are difficult to clinically interpret. A simplified set of TMS 
parameters that are easier to interpret would have better utility in a clinical 
setting. Furthermore, these measures could provide us with meaningful insights 
into the extent of UMN involvement contributing to the overall disease severity. 
The identification of a set of TMS parameters that enable ALS disease severity 
prediction was the goal of this study. 
 
Methods: 
Subjects and ethical review of procedures: 
An approval to perform TMS and clinical assessments of disease severity 
was obtained from an institutional review board. Thirty eight subjects with clinical 
features and diagnosis consistent with motor neuron disease (MND) were 
included in this study. There were no re-imbursements for participating in this 
study (see supplementary methods). 
 
Disease severity measures: 
The disease severity of subjects with ALS was measured using 
ALSFRSr(5) and AALS(6). The ALSFRSr is an easy to administer scale and a 
strong indicator of survival and global function (5). It is well-suited for identifying 
any possible relationship between disease severity and TMS parameters. Since, 
all motor evoked potentials (MEP) following TMS were recorded from abductor 
digiti minimi (ADM), these MEP recordings directly represent the degree of upper 
extremity UMN dysfunction. However, ALSFRSr lacks an objective measurement 
of upper extremity functional loss, a requirement for direct comparison of TMS 
results. The AALS on the other hand is based on a weighted score approach 
using a variety of subcomponent measures. Therefore, the AALS was included 
here as a secondary disease severity measure. 
 
The subcomponents of AALS include: FVC, timed 20ft walking test, timed 
standing up from a chair, timed standing up from lying down, timed climbing up 
and down 4 steps of stairs, timed propelling of wheelchair 20ft, grip force testing 
using dynamometer, pinch grip testing using pinch gauge, Purdue peg board 
test, block-and-board test and manual muscle testing for both upper and lower 
extremities(5). Each of these variables has an independent predictive value for 
ALS disease severity. The individual measures used in this scale allowed us to 
dissect specific upper extremity dysfunction and a subcomponents analysis of 
AALS was therefore important. Also, ALSFRSr and AALS have unique 
characteristics as disease severity measures in ALS (7), hence the relevance of 
comparison of both measures.  
 
Another key disease severity measure was the impact of ALS disease 
process on quality of life(8). The McGill quality of life single item scale 
(MQoLSiS) is an easy to administer scale that can measure ALS related quality 
of life changes (9). We independently recorded ALSFRSr, total AALS scores and 
MQoLSiS for disease severity, along with raw measurement values for all the 
individual clinical measures that constituted AALS. 
 
TMS and peripheral nerve stimulation: 
 During each visit, the following TMS parameters were recorded: MEP 
amplitude, central motor conduction time (CMCT), TST amplitude ratio (rAmp) 
and TST area ratio (rArea). Motor threshold estimation using MEP/CMAP with a 
likelihood of >50% was used as a measure for cortical excitability(10). Latency 
measurements from F-wave responses were used to calculate CMCT. The motor 
cortex stimulation was performed using a MagPro R-30 (MagVenture Inc., 
Alpharetta, GA, USA) magnetic stimulator with a figure-of-eight (butterfly) 
geometry MC-B70 coil (MagVenture Inc., Alpharetta, GA, USA). A figure-of-eight 
coil has a better ability to localize the area of stimulation than a traditional circular 
coil as demonstrated below.  
 
The electrical stimulations of Wrist (Wr) and erb’s point (Ep) along with the 
corresponding electromyography (EMG) recordings were performed using an 
EMG console (Natus Neurology Incorporated, Middleton, WI, USA). For the Wr 
and the Ep electrical stimulation, adhesive 2cm diameter Ag/AgCl disposable 
electrodes (Natus Neurology Incorporated, Middleton, WI, USA) were used. 
Similar adhesive electrodes were used to record the responses from ADM 
muscle (see supplementary methods). 
 
For maximal activation of the corticomotoneuronal pathway using the 
figure-of-eight coil; a biphasic, counterclockwise current direction pulse was 
used(11). The stimulation intervals for performing the study were calculated by 
the TST software. The three sites of stimulation for TSTtest were the motor cortex 
– Wr – Ep. The TSTtest responses represent the fraction of surviving motor 
neurons in the corticospinal tract and were the result of timed collisions dictated 
by the software. The TSTcontrol recordings were made to rule out any peripheral 
nerve conduction abnormalities by applying Ep – Wr – Ep sequential 
stimulations. The amplitude and area under the curve of the TSTtest and TSTcontrol 
responses were used to calculate the TST amplitude and area ratios (12).  
 
TMS computational model:   
 We developed three-dimensional (3D) computational models to 
investigate and compare the induced electric (E) field distributions generated by 
two different TMS coils: 1) a traditional circular coil (MagVenture C-100) and 2) 
the MagPro R-30 stimulator with MC-B70 figure-of-eight coil. The fields were 
computed using the Comsol AC/DC module with the Magnetic Fields (mef) 
physics interface, version 5.2 (see supplementary methods) (13). The coils 
were energized using a biphasic sinusoidal current. The resultant E fields for the 
two coil geometries subjected to this excitation are shown in figures 1a,b (see 
also, supplementary methods). This analysis shows clear differences between 
the field distributions of the two coil configurations. Specifically, the figure-of-eight 
coil produces a much more spatially focused E field than the circular coil, which 
is consistent with previous studies (14). 
 
Analysis and prediction model: 
 Statistical analyses were performed using R 64 bit for Microsoft Windows, 
version 3.3.1(15). A supervised machine learning (ML) model using random 
decision trees(16, 17) was built using various parameters collected during this 
study. The goal of this ML model was to develop an accurate predictor for 
ALSFRSr scores. The ML model was tested against a double-blinded ALS 
disease severity dataset that was collected after its development. The ML model 
was also compared against a multiple linear regression model (MLR) for 
predicting ALSFRSr scores (see supplementary methods).  
 
Results: 
Clinical population: 
Following screening, a review of patient charts and the administration of 
informed consent, 38 subjects were included in the motor neuron disease (MND) 
category and underwent TMS. Applying Shapiro-Wilk test of normality on the 
age distribution of the subjects included in the study, the normality (p=0.60) of 
the sample population was established. All 38 subjects had either suspected, 
possible, probable, laboratory supported definite, or definite ALS according to El-
Escorial criteria. The group comprised of 23 men with an average age of 56.26 
(SD=11.76) years and 15 women of average age 57.87 (SD=7.69) years. The 
average duration of the disease for men was 2.52 (SD=2.66) years and for 
women, 3.80 (SD=5.03) years with no significant difference in disease duration 
between the two gender groups.  
 
Among the 38 subjects, 12 had findings limited to UMN dysfunction 
lasting for more than 4 years. Significant bulbar dysfunction in the form of 
dysarthria, swallowing difficulty or respiratory problems was identified in 8 
subjects. A bulbar predominant disease process, with minimal or no involvement 
of upper or lower extremities were observed in 4 subjects.  
 
The average ALSFRSr score for men was 41.18 (SD=5.38) and 37.33 
(SD=6.72) for women. A statistically significant difference was observed in 
ALSFRSr scores (p=0.01, 95% CI: 0.90, 6.80) between the two genders. The 
average AALS score for men was 49.86 (SD=14.94) and 55.27 (SD=19.72) for 
women. The mean quality of life as measured using McGill quality of life single 
item (MQoLSiS) questionnaire for men was 7.27 (SD=1.93) and 6.87 (SD=2.60) 
for women. No significant differences in AALS and MQoLSIS scores were 
observed between the two genders. 
 
The average pain or discomfort associated with the neurophysiology 
procedures were measured using visual analog scale. The scale reported an 
average discomfort of 4.00 (SD=2.83) for men and 3.80 (SD=3.02) for women 
with no significant difference in tolerating the procedure between the two 
genders. 
 
Triple stimulation test ratio: 
 A simple linear regression was calculated to predict the dexterity task 
performances based on the triple stimulation test. A significant linear relationship 
was observed between triple stimulation test results and both the dexterity tasks 
used in this study. For block-and-board test based on the TST amplitude ratio 
(rAmp) resulted in a significant regression equation (F(1,72)=62.82, R2=0.46, 
p<0.01). Another simple linear regression using rAmp significantly predicted the 
Purdue peg board results (F(1,72)=37.16, R2=0.33, p<0.01).  A significant linear 
relationship was also observed between triple stimulation test results and both of 
the objective measures of upper extremity strength. The resultant simple linear 
regression equations based on rAmp significantly predicted both the grip force 
(F(1,72)=8.57, R2=0.09, p<0.01) and  lateral pinch grip strength (F(1,72)=4.93, 
R2=0.05, p=0.03). 
 
 
 
Other TMS and neurophysiology findings: 
 An MEP response was observed in 29 subjects (76.32%) upon 
stimulation of both hemispheres. Absent MEP responses occurred in 7 subjects 
(18.42%). Two subjects (5.26%) had MEP responses from only one cortical 
hemisphere. Among those with absent MEPs 5 subjects (71.43%) had 
associated bulbar symptoms. Bulbar symptoms accompanied a significantly 
lower ALSFRSr score (p<0.01, 95% CI: 1.74, 8.24), MEP amplitude (p<0.01, 
95% CI: 0.56, 2.37) and rAmp (p=0.04, 95% CI: 1.14, 42.02), compared to 
subjects without bulbar symptoms. Bulbar symptoms were also accompanied by 
a significantly higher motor threshold (p<0.01, 95% CI: -22.93, -3.54). No 
significant differences in CMAP amplitudes were observed between subjects 
with prominent bulbar symptoms and those without. A significant linear 
relationship was observed between CMCT, motor threshold and rAmp. The 
resultant simple linear regression equations using rAmp significantly predicted 
the CMCT (F(1,74)=113.70, R2=0.60, p<0.01) and the motor threshold 
(F(1,74)=145.3, R2=0.66, p<0.01). Both CMCT and motor threshold showed 
inverse linear relationship with rAmp. 
 
Predicting disease severity using neurophysiological measures: 
Using simple linear regression, we found that changes in rAmp was a 
significant predictor of disease severity measurements using ALSFRSr 
(F(1,72)=19.35, R2=0.20, p<0.01) and AALS (F(1,72)=11.03, R2=0.12, p<0.01). 
Simple linear regression models using the motor threshold and CMCT also 
significantly predicted both ALSFRSr (F(1,72)=13.5, R2=0.15, p<0.01), 
(F(1,72)=19.49, R2=0.20, p<0.01) and AALS (F(1,72)=6.70, R2=0.07, p=0.01), 
(F(1,72)=14.46, R2=0.16, p<0.01)) disease severity scores respectively. A 
summary of all the linear correlations between ALSFRSr scores and TMS 
parameters are shown in figure 2a. 
 
Combining the TMS parameters together resulted in a significant multiple 
linear regression equation (F(6,67)=4.35, R2=0.22, p<0.01). But, this MLR model 
constrained to the TMS data, needed improvement due to: 1) only accounting for 
a small proportion of the variability in ALSFRSr disease severity scores and 2) 
the floor effect of the prediction model. Therefore, to improve the prediction 
model, we combined both clinical and neurophysiological data. A correlation 
heat map (figure 2b) and the islands of statistically significant correlations plot 
(figure 2c), helped estimate the relative importance of each variable and build 
the MLR model for ALSFRSr prediction (see supplementary methods). The 
resultant MLR model accounted for a very high variance and significantly 
predicted the ALSFRSr scores (F(21,46)=21.37, R2=0.86, p<0.01). But, this 
prediction model was less reliable due to: 1) the failure to identify an accurate 
relationship between ALSFRSr score and several of the predictor variables and 
2) poor precision for the predicted values. 
 
Therefore, the pooled dataset collected in this study was used to build a 
random forest based supervised ML model. Each variable used in this ML model 
had a unique significance in helping predict the disease severity (see 
supplementary methods). Since the variance accounted for by the MLR and 
ML prediction models were nearly 90%, a sample size of 38 subjects gave a 
statistical power of 99.96% for our conclusion that the MLR and ML based 
prediction models described here were significantly useful for disease prediction 
in ALS.  Also, a subsequent double-blinded testing showed no significant 
differences between predicted and observed values for both MLR and ML 
models, with the ML model registering increased accuracy and precision, over 
the MLR model.  
 
Significantly, the random forest based supervised ML model was capable 
of predicting disease severity with an overall accuracy of >97% and a precision of 
>99% (table 2, figure 3a,b). Other notable findings were: 1) the local weighted 
smoothening for the ALSFRSr - triple stimulation test data demonstrated an initial 
flattened disease progression slope; 2) for the corresponding degree of UMN 
dysfunction, both the regression lines and the local weighted smoothening lines 
for the ML prediction values closely followed those for the observed ALSFRSr 
values (figure 3c).  
 
Discussion: 
Transcranial magnetic stimulation (TMS) follows Faraday-Maxwell’s laws 
of electrodynamics (18). A brief duration electrical current due to a rapidly varying 
magnetic field is induced in the cortical interneurons. The TMS recordings are 
often highly variable, due to the nature of how MEPs are generated. The triple 
stimulation technique (TST) was developed to reduce some of the inherent 
variability with TMS. The amplitude ratio of TST is representative of the fraction 
of the functional network of neurons in the corticospinal tract(19). The central 
motor conduction time (CMCT) quantifies the loss of fastest conducting neurons 
in the corticospinal tract network(20) and despite its test-retest variability, the 
longitudinal changes in CMCT has been shown to be a predictor of disease 
severity(21). Here, we demonstrate for the first time the role of cross-sectional 
measures of TST amplitude and area ratios, CMCT and motor threshold TMS 
parameters to be independently useful in predicting the degree of clinical 
impairment in ALS. We also successfully tested the ML prediction model for ALS 
disease severity. 
 
Our modeling of the decaying magnetic field strength and the primary 
electric field induced on the surface of the brain, showed a significantly focal 
electric E field while using a figure-of-eight coil (figure 1a,b). A more focal field 
increased the accuracy and precision of the TMS recordings by selective 
activation of ADM. Another important requirement for accurate TST recordings 
was the nature of the TMS pulse. Usually single pulse protocols rely on a 
monophasic stimulation pulse. Since TST is dependent on maximal activation of 
the motor cortex neurons, our use of a biphasic pulse was important 
(supplementary methods). Improvement of TMS parameters based on physical 
properties of the brain stimulation coil, produced accurate TMS and TST 
recordings.  
 
An important clinical finding is the strong concordance between measures 
of dexterity and TMS parameters. Clinical studies that measure 
corticomotoneuronal change usually include dexterity measures that involve 
timed repetitive fine-motor tasks. The degree of corticomotoneuronal dysfunction 
as measured by TST scores significantly predicted timed fine-motor repetitive 
tasks like block-and-board test and the Purdue peg board tests. We also found 
that hand weakness was also significantly influenced by corticomotoneuronal 
dysfunction. We also observed a significant correlation between CMAP amplitude 
and all four of the TMS parameters. Similar to previous studies, we noticed an 
inverse relation between distal CMAP amplitude and motor threshold (22). These 
findings together are suggestive of a possible influence of corticomotoneuronal 
dysfunction on motor units.  
 
An exception to this inverse relation between the CMAP amplitude and the 
motor threshold was observed among subjects with bulbar symptoms. Bulbar 
symptoms usually accompany in-excitable motor cortex(23). This finding was 
consistent with our observation of significantly increased motor threshold, lower 
MEP amplitudes and lower TST amplitude ratios, despite robust CMAPs that 
accompanied bulbar symptoms. Since the neurophysiological effect of TMS is 
mediated predominantly through recruitment of the population of interneurons, 
these findings suggest an underlying upper motor neuron pathophysiology 
causing bulbar symptoms. These findings also suggest a differential involvement 
of motor cortex neuronal population in different phenotypes of ALS and are worth 
further exploration. 
 
We also observed that an initial flattening of the ALSFRSr slope occurred 
among subjects with early corticomotoneuronal involvement. This flattening of 
the ALSFRSr slope could be explained in the context of ‘e pluribus unum’ model 
analysis of ensembles of accumulators(24), which found that firing rates are 
largely invariant with respect to ensemble size if the accumulators share at least 
modestly correlated accumulation rates. The subset of neurons with properties 
that can be considered outliers compared to the rest did not significantly alter the 
network properties. This model along with the neurophysiological findings of our 
study can explain some of the underlying motor cortical changes associated with 
ALS.  
 
The initial flat slope of ALSFRSr in relation to the TMS parameters can be 
viewed as a state where the overall functional motor network characteristics 
undergo slower alterations compared to exponential loss in ensemble 
accumulators, an outcome due to the compensatory nature of the motor 
networks. Only when the neuronal loss exceeds a very large value, is a 
significantly observable influence in disease severity and neurophysiological 
changes recorded. These findings of an initial slow progression of the disease 
are also consistent with recent observations of cortical changes as the primary 
event in the disease process (25). The presence of a relatively stable curve of 
early disease progression compared to a greater functional loss of 
corticomotoneurons, followed by a rapid deterioration in clinical functions helps 
explain the non-linear disease progression pattern in ALS(26) and needs further 
investigation.  
 
As an isolated clinical tool, TST is extremely useful due to its small range 
of normal values. For simple stratification as normal or abnormal findings, the 
TST recordings are easier to interpret than other TMS parameters. But this 
simple stratification alone had very little significance in predicting disease 
severity. Despite its small range for normal values and a significant correlation 
with disease severity measures, the TST scores were only moderately strong 
predictors of disease severity. This was applicable for all other individual TMS 
measures used in this study. However, both clinical and neurophysiological 
measures, when pooled together using random forest based supervised ML, the 
ALS disease severity prediction was improved with over 97% overall accuracy, 
99% precision and accounting for nearly 90% of the variance in ALSFRSr scores. 
 
Both the MLR and ML models were significant predictors of ALSFRSr 
scores. This indicates the robustness of the predictor variables used in both MLR 
and ML models. But, there is scope for improvement in accuracy, precision and 
ability to estimate the variations in disease progression. There have been 
previous proposals for combining ML and cortical excitability parameters (27). 
Combining additional TMS measures like the cortical silent period, input-output 
curve and paired pulse stimulation protocols might help add greater predictive 
power to the ML model. Also, neurophysiology measures and imaging measures 
have shown definite promise in identifying ALS disease severity (28). Therefore 
the usefulness of measures like motor unit number estimation and neuroimaging 
data including magnetic resonance (MR) spectroscopy, susceptibility weighted 
imaging and diffusion tensor imaging for improvement of the ML model, also 
need to be evaluated. 
 
In previous studies, the utility of TST as a measure to predict structural 
abnormalities in ALS (29) and improve diagnostic accuracy of ALS has been 
demonstrated (30). In our study, we demonstrate for the first time that cross 
sectional TST measures are moderately strong, significant predictors of disease 
severity on their own. Using ML, this predictive power could be significantly 
boosted. The TST amplitude and area ratios were identified as important 
variables for disease severity prediction. Combining various clinical and 
neurophysiological measures with TST scores significantly improved the ability of 
the ML model to identify small changes in ALS disease severity. As a 
neurophysiology procedure, TST is no more time consuming or painful than a 
proximal erb’s point stimulation and information from this procedure is easy to 
interpret. In conclusion, quantifying corticomotoneuronal dysfunction using upper 
extremity TST is extremely useful and should be included in a TMS study of ALS 
subjects. The random forest based cross-sectional ALSFRSr score prediction 
technique utilizing TST is a potential future biomarker for ALS disease severity. 
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Figures and tables; 
 
Description Status 
Random forest regression 
Number of trees 2000  
No. of variables tried at each split 7 
Mean of squared residuals 4.28 
Variance in ALSFRr scores explained 88.47% 
Multiple linear regression 
Number of variables in the model 21 
Mean of squared residuals 5.23 
Variance in ALSFRr scores explained 
(adjusted R2) 
86.1% 
Significance level (p)  <0.01 
Table 1: Summary of the characteristics of supervised random forest based 
machine learning and multiple linear regression models for ALSFRSr score 
prediction. 
 
Type of the model Precision SD Accuracy SD 
Random forest 
regression 
Overall 99.42% 0.65% 97.56% 3.70% 
Blinded data 99.22% 0.43% 92.06% 6.52% 
Multiple linear 
regression  
Overall 96.95% 3.76% 95.39% 6.38% 
Blinded data 97.53% 3.67% 86.62% 10.96% 
Table 2: Comparison of mean absolute error (MAE) and root mean squared error 
(RMSE) for machine learning and the multiple linear regression models. 
 
 
 
(a) (b) 
  
    
Figure 1: Computational modeling of E fields: (a) predicted E field norm 40 mm from the center of a circular coil, (b) 
predicted E field norm 40 mm from the center of a figure-of-eight coil.
(a) 
 
(b) (c) 
  
Figure 2: Summary of the correlations observed between ALS disease severity 
and different clinical/neurophysiological measures: (a) matrix plot summarizing 
the significant (p<0.05) linear correlations between various TMS parameters, and 
ALS disease severities as measured using ALSFRSr, (b) heat-map plot 
summarizes the strength of correlations between all the modeling variables, (c) 
the islands of statistical significance plot highlights the significant (p<0.05) linear 
correlations between all the modeling variables. 
(a)  
 
(b) (c) 
 
 
 
 
Figure 3: Summary plots of the accuracy and precision of the machine learning (ML) disease 
severity for ALS prediction model: (a) histogram density plot of the accuracy and precision 
errors for the machine learning (ML) model and their corresponding normal distributions, (b) 
overall accuracy and precision errors for the multiple linear regression (MLR) and ML models 
compared against the blinded-test accuracy and precision errors for both models, (c) scatter 
plot comparison of TST amplitude ratio versus the observed (blue) and the ML predicted (red) 
ALSFRSr scores, with an overlay of simple linear regression (dotted) and local weighted 
smoothening (solid) lines.  
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Supplementary methods: 
 
Magnetic field strength modeling: 
 An understanding of physical mechanisms and properties of TMS is important in 
reducing measurement variability (1). Since the E field produced by the TMS coil(s) plays a 
critical role in this process, it is instructive to examine its spatial distribution for traditional coil 
configurations. To this end, we developed 3D computational models to investigate and 
compare the E field distributions generated by two different TMS coils, a circular coil 
(MagVenture C-100) and a butterfly, or “figure-of-eight” coil: the MagVenture MC-B70 model.  
 
The B and E fields generated by the coils were computed using the Comsol 
Multiphysics AC/DC module with the Magnetic Fields (mef) physics interface on Microsoft 
Windows, version 5.2(2). This program solves the Maxwell system of equations [1]-[8] in the 
frequency-domain: 
∇ × 𝐇 = 𝐉          [1] 
𝐁 = 𝛁 × 𝐀          [2] 
𝐄 = −
𝜕𝐀
𝜕𝑡
− ∇ ∙ V          [3] 
𝐉 = 𝛔𝐄 +
𝝏𝐃
𝝏𝒕
+  𝐉𝐞          [4] 
𝛁 ∙ 𝐉 = 𝟎          [5] 
𝐃 = 𝜀0𝜀𝑟𝐄          [6] 
𝐁 = 𝜇0𝜇𝑟𝐇          [7] 
𝐧𝟐 ∙ (𝐉𝟏 − 𝐉𝟐) = 0          [8] 
where, E is the electric field intensity, D is the electric displacement, H is the magnetic field 
intensity, B is the magnetic flux density, J is the total current density, A is the magnetic vector 
potential, ε0 is the permittivity of vacuum, εr is the relative permittivity of a medium, μ0 is the 
permeability of vacuum, μr is the relative permeability, σ is the electrical conductivity, Je is the 
applied current density, i.e. the current density imposed in the coils, V is the electric scalar 
potential and n2 is the outward normal from medium 2 at interfaces between two media (J1 
and J2 are respectively the current densities of medium 1 and 2).  
 
The Comsol Multiphysics software solves eqs. [1]-[8] numerically using the finite 
element method. The inputs to the computational models include the coil energization Je, the 
material domains with corresponding boundaries, the material properties (magnetic, electric 
and dielectric) and appropriate physical boundary conditions. The coils’ energization 
parameters were: a biphasic sinusoidal current with a peak magnitude of 690.7 A per turn and 
a frequency of 3571 Hz, which was modeled by extending a 280 μs sinusoidal biphasic pulse 
into a steady-state signal. The biphasic (full-sine) pulse is detailed in the MagPro user guide 
(Pg. 18). The coil current peak magnitude was derived from the peak di/dt value (155 A/µs) 
displayed by the MagPro R-30 during actual usage of the coils. The models were 
implemented using rectangular prism computational domains (CDs), wherein the TMS coil 
was surrounded by air (figures S1a,b). Three-dimensional meshes of tetrahedral linear 
elements of second order were used to tessellate the entire CD. The dimensions of the CD 
were increased and the meshes were refined until a stable solution and convergence errors 
lower than 1% were achieved. The details of the computational models are summarized in 
table S1. The physical dimension data for the C-100 and MC-B70 coil material domains were 
taken from the coil vendor (3, 4).  
 
Simulations were carried out using the linear Flexible Generalized Minimum Residual 
(FGMRES) iterative solver with 10,000 maximum number of iterations. This solver avoided 
out of memory problems, provided a fast convergence and computing robustness. A fully 
coupled approach using an automatic Newton method was chosen with a minimum damping 
factor of 1x10-4 since it can ensure convergence effectiveness. These parameters were 
chosen because the initial conditions are well-known wherein all electromagnetic quantities 
are set to zero. The models were computed on a Precision® T7610 workstation (Dell 
Technologies Inc., Round Rock, TX, USA) with a 24 core Xeon® E5-2697 v2 processor (Intel 
Corp., Santa Clara, CA, USA) and using 64 GB DDR3 memory. The analysis for each coil 
took approximately 20 minutes to complete. 
 
Screening and subject selection: 
 A total of 57 subjects were screened from a database within a neuromuscular clinic 
population. From this screening pool of 57 subjects, 38 were included in the motor neuron 
disease (MND) category and underwent TMS, registering a screen failure rate of 33.33%. 
Among those 19 subjects who were screen failures 9 (47.37%) did not meet the diagnostic 
criteria, 7 (36.84%) were cancellations or voluntary withdrawal from the research study, 2 
(10.53%) were due to the severity of the disease preventing them to undergo the procedure 
and 1 (5.26%) due to the discomfort associated with the procedure. 
 
Recordings of the CMAP, erb’s point, F-wave and MEP responses: 
 The supramaximal distal compound muscle action potential (CMAP) and erb’s point 
responses were required to perform TST. These responses were determined using an 
incremental stimulation intensity technique. The threshold surface electrode current required 
to elicit a ≥75μV amplitude response at 100μV sensitivity window from the ADM, was 
determined. The threshold response intensity was increased to four fold and a second set of 
responses were recorded. The corresponding responses were considered as the 
supramaximal distal CMAP and erb’s point recordings. The stimulation intensity was 
increased by 5% to identify the plateauing of supramaximal response amplitudes. Among 
subjects in whom plateauing of the responses could not be elicited, stimulation intensity was 
increased by 5% intervals until a plateauing was observed. The corresponding responses 
were identified as the supramaximal distal CMAP and erb’s recordings, among those 
subjects.  
 
A band-pass setting of 2 Hz - 10 kHz without 60Hz filtering was used for all the TST 
acquisitions(5). To measure the F-wave latency, a set of 10 supramaximal stimulation 
responses were recorded. The late responses were recorded at sensitivity windows of 100 
μV, with a bandpass setting of 2Hz – 3kHz, and no 60Hz filtering. The late response 
waveforms were averaged and the earliest late response was used to calculate the F-wave 
latency. The CMCT was calculated using the equation [9], 
 
    𝐂𝐌𝐂𝐓 = 𝑀𝐸𝑃𝑙𝑎𝑡𝑒𝑐𝑛𝑦 −
𝐹−𝑤𝑎𝑣𝑒𝑙𝑎𝑡𝑒𝑛𝑐𝑦+𝐷𝑖𝑠𝑡𝑎𝑙 𝐶𝑀𝐴𝑃𝑙𝑎𝑡𝑒𝑛𝑐𝑦−1
2
           [9] 
 
where, F-wave latency was used to compute the peripheral nerve conduction delay that 
occurred between the anterior horn of the spinal cord and the ADM(6). 
 
All study related recordings were performed in a specially designed room to minimize 
electrical interference. All recordings were made while the subject was sitting upright. The 
side from where the responses were recorded was suitably stabilized. The elbow joint was 
flexed at ~90° angle. The hands were in a supinated position. For MEP recordings, the initial 
placement of the stimulating coil was in such a way that the point of maximal magnetic field 
strength was along an imaginary point on the scalp, 4-5cm lateral to the vertex. The coil’s 
longitudinal axis was in the anterior-posterior direction. The horizontal axis was along 45 
degrees to an imaginary line connecting the vertex and tragus. The point of optimal 
stimulation for the region of the motor cortex that controls the fifth digit was identified by 
measuring the ADM responses and adjusting the positioning of the coil accordingly. 
Contralateral facilitation of the same muscle groups was performed in some subjects to 
optimize the MEP recordings. During facilitation, an auditory feedback was used to maintain a 
muscle contraction of ~20-30% of the maximal effort.  
 
Multiple linear regression model: 
 Due to the inherent challenges associated with neuroscience data, both MLR models 
and supervised ML, have their own benefits and pitfalls in pattern predictions (7, 8). 
Therefore, testing both sets of models was important. First MLR model used only the TMS 
parameters. The resultant linear eq. [10], 
 
    𝐀𝐋𝐒𝐅𝐑𝐒𝐫 = ∑ 𝛼𝑖𝑥𝑖
𝑛
𝑖 + 20.82    [10] 
 
where, αi is the coefficient for the variable xi and n is the total number of variables in the 
predictor model (table S3). Due to the limitations in the TMS model a more detailed MLR 
model using a combination of both clinical and neurophysiological data was developed for 
ALSFRSr score prediction. The resultant linear eq. [11], 
  
    𝐀𝐋𝐒𝐅𝐑𝐒𝐫 = ∑ 𝛽𝑖𝑥𝑖
𝑛
𝑖 + 40.27   [11] 
 
where, βi is the coefficient for the variable xi and n is the total number of variables in the 
predictor model (table S4). This MLR model was compared against the supervised ML based 
model that used the same predictor variables. 
 
Machine learning model for ALSFRSr prediction: 
 The random forest based supervised machine learning prediction model has been 
successfully tested for ALSFRSr score predictions from longitudinal data (9, 10). Using this 
supervised machine learning technique, a cross sectional ALSFRSr score predictor was 
developed as part of this study. A total of 21 variables were used in the ensemble training by 
developing predictor vectors for the random forest regression (table S2a,b). The relative 
importance of each of the predictors was estimated using mean increase in error and mean 
increase in node purity (figure S2a,b). Using a total of 1280 random objects generated with 
Marsenne twister pseudorandom generator that can be reproduced (11), a forest of 2000 
trees was built and tested (figure S2c). Random number generators are implemented at the 
architectural level for newer generation microprocessors (12, 13). But, to ensure a wider 
compatibility and better reproducibility of the prediction code, a pseudorandom number 
generator implementation was used here. The machine learning computations can be 
performed with minimal computational overhead. The prediction models were tested in 
OptiPlex® 9010 workstation (Dell Technologies Inc., Round Rock, TX, USA) with a 4 core 
Core® i7-3770 processor (Intel Corp., Santa Clara, CA, USA), 4GB DDR3 memory. The 
necessary code for running the prediction model and de-identified datasets are available on 
GitHub (14). 
 
Statistical tests and testing of the prediction models: 
The descriptive statistics and within group analysis were done using the code published in 
the GitHub repository. The outputs from the statistical testing of the dataset are also included 
here (14). The two-sample Welch’s unequal variance t-test was used to identify significant 
differences within groups. Using the initial recruitment of 35 subjects, the MLR and ML 
models were developed, followed by an addition of three subjects to the study pool; two 
females and one male. Two had features of bulbar predominant motor neuron disease. These 
three subjects were used to build a blinded-test data by blinding the observed ALSFRSr 
scores from the prediction scores. These de-identified blinded datasets are also included in 
the GitHub repository (14). One of the subjects in the blinded-test dataset underwent the 
same list of procedures four years prior. Since the goal of this study was to identify cross-
sectional neurophysiology and clinical data for ALSFRSr score prediction, this particular 
dataset was treated as a unique cross-sectional data-point. Addition of this subject also 
helped in identifying any possible pitfalls in ML model while handling longitudinal data instead 
of cross-sectional data. Various prediction models were tested against this blinded-test data. 
 
 The accuracy, precision and corresponding standard deviations (SD) for both the final 
prediction models using MLR and ML were calculated using eqs. [12, 13, 14], 
  
                            ∆𝒂𝒄𝒄𝒖𝒓𝒂𝒄𝒚= ∑ (|𝟏 −
𝑨𝑳𝑺𝑭𝑹𝑺𝒓𝑶𝒃𝒔𝒆𝒓𝒗𝒆𝒅−𝑨𝑳𝑺𝑭𝑹𝑺𝒓𝒑𝒓𝒆𝒅𝒊𝒄𝒕𝒆𝒅
𝑨𝑳𝑺𝑭𝑹𝑺𝒓𝑶𝒃𝒔𝒆𝒓𝒗𝒆𝒅
|) × 𝟏𝟎𝟎𝒏𝒊=𝟏  [12] 
 
                    ∆𝒑𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏= ∑ (|𝟏 −
𝑨𝑳𝑺𝑭𝑹𝑺𝒓𝒑𝒓𝒆𝒅𝒊𝒄𝒕𝒆𝒅.𝒓𝒊𝒈𝒉𝒕−𝑨𝑳𝑺𝑭𝑹𝑺𝒓𝒑𝒓𝒆𝒅𝒊𝒄𝒕𝒆𝒅.𝒍𝒆𝒇𝒕
𝟒𝟖
|) × 𝟏𝟎𝟎𝒏𝒊=𝟏      [13] 
 
                                          ∆𝑺𝑫= √
𝟏
𝒏
∑ (∆𝒊)
𝒏
𝒊=𝟏 × 𝟏𝟎𝟎                                                [14] 
   
where, n is the total number of samples used in the prediction model. Both the MLR and ML 
prediction models computed unique ALSFRSr scores that corresponded to the right and left 
sides of each subject. These values were computed using a combination of both side 
dependent and side independent measures. The resultant values were used to compute the 
precision for both MLR and ML models. Since the ALSFRSr scale values ranges from 0 to 48, 
the maximum possible value for the scale was the denominator for computing percentage 
precision. 
 
The random forest regression is based on random sampling of a vector, such that the 
corresponding tree predictor assumes a numerical value. Therefore the regression results are 
state dependent on the random attributes of the computational environment running the ML 
model. This results in slight differences in outputs for each separate run. The error analyses 
reported here are based on a randomly chosen single run of the prediction model based on 
the parameters described above. The outputs from the successful execution of the code that 
were used for the analyses, are also included in the GitHub repository(14). 
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Supplementary figures and tables: 
 
 
(a) (b) 
  
Figure S1: Computational domain for numerical analysis of B and E fields showing TMS 
coil(s) in air: (a) single coil, (b) figure-of-eight coil. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
  
(c) 
 
Figure S2: Relative importance of each predictor vectors used in the random forest based 
machine learning model for ALSFRSr score prediction: (a) mean decrease in error plot, (b) 
the expected error rate using Gini impurity index during the random splits training of the 
prediction model, (c) relative error rate in predicting ALSFRSr compared against the number 
of prediction trees used to build the ML model. 
 
Simulation  
type 
 
Relative 
electric 
permittivity 
Electric 
conductivity 
(S/m) 
Relative 
magnetic 
permeability 
Dimensions Total number 
of tetrahedral 
and boundary 
mesh 
elements 
Degrees-
of-
freedom 
C-100  
  
  
  
  
1 
  
  
  
  
6.0 x 107 
  
  
  
  
1 
  
  
  
  
Coil Coil height: 6 mm 455733 4135240 
Outside diameter: 110 mm 
Inside diameter: 20 mm  
Cross sectional area (wire): 
19.29 mm2  
Length (wire): 3 m 
Air 
block 
Width (x): 500 mm 
Depth (y): 500 mm 
Height (z): 750 mm 
MC-B70 1 6.0 x 107 1 Coil Coil height: 6 mm 505332 4612009 
Outside diameter: 97 mm 
Inside diameter: 27 mm 
Cross sectional area of 
wire: 21 mm2 
Length (wire): 3 m 
Air 
block 
Width (x): 500 mm 
Depth (y): 500 mm 
Height (z): 750 mm 
Table S1: Details of dimensions of computational domain, dielectric and magnetic properties of materials and media used for 
simulation of the C-100 and MC-B70 TMS coils. 
 
 
 
 
 
 
 
 
Vector Description of the vector Mean decrease in error Increase in node purity 
V1 Age in years 14.49 54.60 
V2 Body mass index 9.87 38.64 
V3 McGill single item quality of life score 12.40 39.48 
V4 TST amplitude ratio as percentage 0.77 17.04 
V5 TST area ratio as percentage 3.37 26.37 
V6 MEP:CMAP amplitude ratio 6.84 35.13 
V7 MEP: proximal stimulation amplitude ratio 5.26 27.80 
V8 Inverse of central motor conduction time measured in milliseconds  7.82 33.82 
V9 Motor threshold as a percentage of the maximal output of the TMS stimulator 2.79 9.76 
V10 Forced vital capacity as percentage of the predicted 15.00 47.31 
V11 Inverse of the time to complete walking 20ft measured in seconds 35.56 672.24 
V12 Inverse of the time to standup from a chair measured in seconds 26.17 414.26 
V13 Inverse of the time to climb up and down 4 steps of stairs measured in seconds 26.31 231.18 
V14 Inverse of the time to propel a wheelchair 20ft measured in seconds 28.89 434.36 
V15 Grip force testing using Jamar dynamometer in kg 21.34 142.17 
V16 Lateral pinch grip in kg 13.22 55.89 
V17 Timed Purdue peg board test 12.12 62.14 
V18 Timed block and board test 7.15 57.52 
V19 Manual muscle strength testing of the upper extremity using MRC scale 5.73 9.58 
V20 Manual muscle strength testing of the lower extremity using MRC scale 4.21 12.94 
V21 Duration of the disease in years 8.44 29.20 
V22 Gender (0=male, 1=female)  
 
 
 
 
Unused vectors for the ML model 
V23 Visual analogue scale 
V24 Presence or absence of bulbar symptoms (0=no, 1=yes) 
V25 Race (1=Caucasian, 2=Black/African American, 3=Asian, 4=Hispanic) 
V26 Handedness (0=left,1=right) 
V27 Smoking status (0=no, 1=yes) 
V28 Distal compound muscle action potential (CMAP) amplitude (μV) 
V29 Proximal stimulation response amplitude (μV) 
V30 Motor evoked potential amplitude (μV) 
Table S2: Description of vectors and relative importance of each one when used for the development of random forest based 
supervised machine learning prediction of ALSFRSr scores (see figure S2a,b). 
Variable Coefficients t value Significance level 
 B Standard error 
(Constant) 20.8195 14.2171 1.464 0.148  
V4 0.14831 0.09111 1.628 0.108  
V5 -0.1174 0.08995 -1.305 0.196  
V6 11.937 8.5384 1.398 0.167  
V7 -0.5043 14.9013 -0.034 0.973 . 
V8 28.6969 20.4667 1.402 0.165  
V9 0.13729 0.14158 0.97 0.336  
Significance codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
Table S3: Summary of the multiple linear regression model using TMS measures 
as independent variables and the ALSFRSr score as the dependent variable. 
 
Variable Coefficients t value Significance level 
 B Standard error 
(Constant) 40.27 13.74 2.93 0.01 ** 
V1 0.05 0.04 1.18 0.24  
V2 0.29 0.11 2.74 0.01 ** 
V3 -0.24 0.15 -1.61 0.12  
V4 -0.01 0.04 -0.26 0.80  
V5 -0.03 0.04 -0.67 0.51  
V6 -5.77 4.85 -1.19 0.24  
V7 13.15 7.27 1.81 0.08 . 
V8 18.87 11.56 1.63 0.11  
V9 0.07 0.08 0.80 0.43  
V10 0.00 0.02 0.11 0.91  
V11 45.31 13.30 3.41 0.00 ** 
V12 1.86 2.59 0.72 0.48  
V13 25.03 7.65 3.27 0.00 ** 
V14 -13.87 12.48 -1.11 0.27  
V15 0.09 0.02 4.66 0.00 *** 
V16 0.01 0.04 0.25 0.80  
V17 0.09 0.08 1.11 0.27  
V18 0.02 0.04 0.59 0.56  
V19 -0.79 0.24 -3.21 0.00 ** 
V20 -0.22 0.11 -2.03 0.05 * 
V21 -0.18 0.10 -1.82 0.08 . 
Significance codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
Table S4: Summary of the multiple linear regression model using a combination 
of clinical and neurophysiology data as independent variables and the ALSFRSr 
score as the dependent variable. 
 
 
 
